RISK OF CORONARY ARTERY DISEASE ASSOCIATED WITH TYPE 2 DIABETES (08-17-09)



Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes

Ok, so the TZDs for diabetes (i.e. Avandia, Actose) have been giving a black box warning for causing heart disease (the number one cause of death in diabetics, I might add). So let’s use the sulfonylureas, right? Well, they’re known to actually damage the beta cells of the pancreas–the very cells we want to protect!!. And, if that wasn’t bad enough, here we see more than a doubling of risk of heart disease with some of the older drugs in this class. Man…if I was an endocrinologist that really wanted to help my patients–I’d burn the prescription pad and open a gym.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Diabetes (Type 2), Heart Disease
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”